Trial Profile
A Phase I Study of Reduced Intensity, Sequential Double Umbilical Cord Blood Transplantation Using ProHema Modulated Umbilical Cord Blood Units in Subjects With Hematological Malignancies.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 May 2014
Price :
$35
*
At a glance
- Drugs FT 1050 (Primary) ; Antithymocyte globulin; Fludarabine; Melphalan; Sirolimus; Tacrolimus
- Indications Haematological malignancies
- Focus Adverse reactions
- Sponsors Fate Therapeutics
- 08 May 2014 New trial record